e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
A morphological view of chest pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases
Daijiro Nabeya (Okinawa, Japan), Daijiro Nabeya, Shusaku Haranaga, Takeshi Kinjo, Gretchen Parrott, Ayako Uehara, Saifun Nahar, Teruhisa Tanaka, Tetsuo Hirata, Futoshi Higa, Masao Tateyama, Jiro Fujita
Source:
International Congress 2015 – A morphological view of chest pathology
Session:
A morphological view of chest pathology
Session type:
Thematic Poster Session
Number:
757
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Daijiro Nabeya (Okinawa, Japan), Daijiro Nabeya, Shusaku Haranaga, Takeshi Kinjo, Gretchen Parrott, Ayako Uehara, Saifun Nahar, Teruhisa Tanaka, Tetsuo Hirata, Futoshi Higa, Masao Tateyama, Jiro Fujita. Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases. Eur Respir J 2015; 46: Suppl. 59, 757
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
Radiologic features of lung involvement in young patients with viral pneumonia
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Amphetamine induced eosinophilic pneumonia: A case report
Source: International Congress 2014 – ILDs 6
Year: 2014
Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Intra-arterial correction of respiratory dysfunction in severe acute pancreatitis
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013
Markers of sudden cardiac arrest in patients with severe respiratory infections
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Features of pneumonia diagnostics in burn trauma patients
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept